Alembic Pharmaceuticals has received USFDA approval for Carbidopa and Levodopa extended-release tablets which is used for treatment of Parkinson’s disease. The drug is therapeutically equivalent […]
Shilpa Medicare has received final USFDA approval for Docetaxel Injection, used for treatment of various types of cancers. The company will market the inaction in […]
Natco Pharma has received final ANDA nod from USFDA for chest pain tablets through its marketing partner Alvogen. The drug Nitroglycerin Sublingual Tablets in strengths […]
Cipla has received the final USFDA approval for the Abbreviated New Drug Application (ANDA) for their Ambrisentan Tablets, 5 mg and 10 mg. The drug […]
Lupin Pharma has received USFDA approval for its Fluoxetine Tablets USP, 10 mg and 20 mg to market the same in US markets. The drug […]
Zydus Cadila has received final USFDA to market Chlorthalidone tablets, used to treat high blood pressure. The drug will be marketed in the strengths of […]
Glenmark Pharma has received final USFDA approval to market a generic version of AstraZeneca’s Nexium, used to treat acid reflux. The drug esomeprazole magnesium delayed-release […]
Alembic Pharmaceuticals has received final USFDA approval for Tadalafil tablets, indicated for the treatment of erectile dysfunction. The drug will be marketed in strengths of […]
Zydus Cadila has received final USFDA approval to market Ambrisentan tablets in in strengths of 5 mg and 10 mg in the American market. The […]
Alembic Pharmaceuticals has received USFDA approval for Azelastine Hydrochloride Ophthalmic Solution used for the treatment of allergic conjunctivitis. The drug is equivalent of Optivar Ophthalmic […]
Copyright © 2024 | WordPress Theme by MH Themes